Loading…

A Case of Autoimmune Encephalitis with Refractory Status Epilepticus

Refractory status epilepticus is usually caused by a severe brain injury and has a high rate of mortality and morbidity despite the infusion of antiepileptic drugs and anesthetic agents. Autoimmune encephalitis is one cause of refractory status epilepticus and status epilepticus may be the initial s...

Full description

Saved in:
Bibliographic Details
Published in:Archives of Epilepsy 2019-01, Vol.25 (3), p.165-168
Main Authors: Merve Melodi ÇAKAR, Aslıhan AKŞAR, Meliha AKPINAR, Elif MERCAN, Sezgin KEHAYA, Babürhan GÜLDİKEN
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 168
container_issue 3
container_start_page 165
container_title Archives of Epilepsy
container_volume 25
creator Merve Melodi ÇAKAR
Aslıhan AKŞAR
Meliha AKPINAR
Elif MERCAN
Sezgin KEHAYA
Babürhan GÜLDİKEN
description Refractory status epilepticus is usually caused by a severe brain injury and has a high rate of mortality and morbidity despite the infusion of antiepileptic drugs and anesthetic agents. Autoimmune encephalitis is one cause of refractory status epilepticus and status epilepticus may be the initial symptom. The seizures are generally resistant to standard treatment and may require immunotherapeutics. This is a description of a patient who had refractory status epilepticus despite appropriate doses of antiepileptic and general anesthetic drugs, but responded to intravenous immunoglobulin therapy. Examinations revealed an ovarian teratoma with a negative serum N-methyl-D-aspartate receptor antibody.
doi_str_mv 10.14744/epilepsi.2019.91259
format article
fullrecord <record><control><sourceid>doaj</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_d2a77112403d4ead9701a3b7fa80129b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_d2a77112403d4ead9701a3b7fa80129b</doaj_id><sourcerecordid>oai_doaj_org_article_d2a77112403d4ead9701a3b7fa80129b</sourcerecordid><originalsourceid>FETCH-LOGICAL-c242t-6715b7248a07a02636336b54a95fcc49f31d390246758876f4549d00abc7057e3</originalsourceid><addsrcrecordid>eNotjstqwzAQRUWh0JDmD7rQDzgdjSTLWoY0bQOBQh9rM5alRsGJjSVT8vctaVYXzuKcy9iDgKVQRqlHP8TODykuEYRdWoHa3rAZGosFaA13bJHSAQDQojTCztjTiq8ped4HvppyH4_H6eT55uT8sKcu5pj4T8x7_u7DSC7345l_ZMpT4ptLKkc3pXt2G6hLfnHdOft63nyuX4vd28t2vdoVDhXmojRCNwZVRWAIsJSllGWjFVkdnFM2SNFKC6hKo6vKlEFpZVsAapwBbbycs-2_t-3pUA9jPNJ4rnuK9QX043dN49-jztctkjFCoALZKk-tNSBINiZQBQJtI38BZrlZHQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A Case of Autoimmune Encephalitis with Refractory Status Epilepticus</title><source>DOAJ Directory of Open Access Journals</source><creator>Merve Melodi ÇAKAR ; Aslıhan AKŞAR ; Meliha AKPINAR ; Elif MERCAN ; Sezgin KEHAYA ; Babürhan GÜLDİKEN</creator><creatorcontrib>Merve Melodi ÇAKAR ; Aslıhan AKŞAR ; Meliha AKPINAR ; Elif MERCAN ; Sezgin KEHAYA ; Babürhan GÜLDİKEN</creatorcontrib><description>Refractory status epilepticus is usually caused by a severe brain injury and has a high rate of mortality and morbidity despite the infusion of antiepileptic drugs and anesthetic agents. Autoimmune encephalitis is one cause of refractory status epilepticus and status epilepticus may be the initial symptom. The seizures are generally resistant to standard treatment and may require immunotherapeutics. This is a description of a patient who had refractory status epilepticus despite appropriate doses of antiepileptic and general anesthetic drugs, but responded to intravenous immunoglobulin therapy. Examinations revealed an ovarian teratoma with a negative serum N-methyl-D-aspartate receptor antibody.</description><identifier>EISSN: 2792-0550</identifier><identifier>DOI: 10.14744/epilepsi.2019.91259</identifier><language>eng</language><publisher>Galenos Yayinevi</publisher><subject>immunotherapy ; intravenous immunoglobulin ; pareneoplastic limbic encephalitis ; status epilepticus</subject><ispartof>Archives of Epilepsy, 2019-01, Vol.25 (3), p.165-168</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,2095,27903,27904</link.rule.ids></links><search><creatorcontrib>Merve Melodi ÇAKAR</creatorcontrib><creatorcontrib>Aslıhan AKŞAR</creatorcontrib><creatorcontrib>Meliha AKPINAR</creatorcontrib><creatorcontrib>Elif MERCAN</creatorcontrib><creatorcontrib>Sezgin KEHAYA</creatorcontrib><creatorcontrib>Babürhan GÜLDİKEN</creatorcontrib><title>A Case of Autoimmune Encephalitis with Refractory Status Epilepticus</title><title>Archives of Epilepsy</title><description>Refractory status epilepticus is usually caused by a severe brain injury and has a high rate of mortality and morbidity despite the infusion of antiepileptic drugs and anesthetic agents. Autoimmune encephalitis is one cause of refractory status epilepticus and status epilepticus may be the initial symptom. The seizures are generally resistant to standard treatment and may require immunotherapeutics. This is a description of a patient who had refractory status epilepticus despite appropriate doses of antiepileptic and general anesthetic drugs, but responded to intravenous immunoglobulin therapy. Examinations revealed an ovarian teratoma with a negative serum N-methyl-D-aspartate receptor antibody.</description><subject>immunotherapy</subject><subject>intravenous immunoglobulin</subject><subject>pareneoplastic limbic encephalitis</subject><subject>status epilepticus</subject><issn>2792-0550</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNotjstqwzAQRUWh0JDmD7rQDzgdjSTLWoY0bQOBQh9rM5alRsGJjSVT8vctaVYXzuKcy9iDgKVQRqlHP8TODykuEYRdWoHa3rAZGosFaA13bJHSAQDQojTCztjTiq8ped4HvppyH4_H6eT55uT8sKcu5pj4T8x7_u7DSC7345l_ZMpT4ptLKkc3pXt2G6hLfnHdOft63nyuX4vd28t2vdoVDhXmojRCNwZVRWAIsJSllGWjFVkdnFM2SNFKC6hKo6vKlEFpZVsAapwBbbycs-2_t-3pUA9jPNJ4rnuK9QX043dN49-jztctkjFCoALZKk-tNSBINiZQBQJtI38BZrlZHQ</recordid><startdate>20190101</startdate><enddate>20190101</enddate><creator>Merve Melodi ÇAKAR</creator><creator>Aslıhan AKŞAR</creator><creator>Meliha AKPINAR</creator><creator>Elif MERCAN</creator><creator>Sezgin KEHAYA</creator><creator>Babürhan GÜLDİKEN</creator><general>Galenos Yayinevi</general><scope>DOA</scope></search><sort><creationdate>20190101</creationdate><title>A Case of Autoimmune Encephalitis with Refractory Status Epilepticus</title><author>Merve Melodi ÇAKAR ; Aslıhan AKŞAR ; Meliha AKPINAR ; Elif MERCAN ; Sezgin KEHAYA ; Babürhan GÜLDİKEN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c242t-6715b7248a07a02636336b54a95fcc49f31d390246758876f4549d00abc7057e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>immunotherapy</topic><topic>intravenous immunoglobulin</topic><topic>pareneoplastic limbic encephalitis</topic><topic>status epilepticus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Merve Melodi ÇAKAR</creatorcontrib><creatorcontrib>Aslıhan AKŞAR</creatorcontrib><creatorcontrib>Meliha AKPINAR</creatorcontrib><creatorcontrib>Elif MERCAN</creatorcontrib><creatorcontrib>Sezgin KEHAYA</creatorcontrib><creatorcontrib>Babürhan GÜLDİKEN</creatorcontrib><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Archives of Epilepsy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Merve Melodi ÇAKAR</au><au>Aslıhan AKŞAR</au><au>Meliha AKPINAR</au><au>Elif MERCAN</au><au>Sezgin KEHAYA</au><au>Babürhan GÜLDİKEN</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Case of Autoimmune Encephalitis with Refractory Status Epilepticus</atitle><jtitle>Archives of Epilepsy</jtitle><date>2019-01-01</date><risdate>2019</risdate><volume>25</volume><issue>3</issue><spage>165</spage><epage>168</epage><pages>165-168</pages><eissn>2792-0550</eissn><abstract>Refractory status epilepticus is usually caused by a severe brain injury and has a high rate of mortality and morbidity despite the infusion of antiepileptic drugs and anesthetic agents. Autoimmune encephalitis is one cause of refractory status epilepticus and status epilepticus may be the initial symptom. The seizures are generally resistant to standard treatment and may require immunotherapeutics. This is a description of a patient who had refractory status epilepticus despite appropriate doses of antiepileptic and general anesthetic drugs, but responded to intravenous immunoglobulin therapy. Examinations revealed an ovarian teratoma with a negative serum N-methyl-D-aspartate receptor antibody.</abstract><pub>Galenos Yayinevi</pub><doi>10.14744/epilepsi.2019.91259</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 2792-0550
ispartof Archives of Epilepsy, 2019-01, Vol.25 (3), p.165-168
issn 2792-0550
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_d2a77112403d4ead9701a3b7fa80129b
source DOAJ Directory of Open Access Journals
subjects immunotherapy
intravenous immunoglobulin
pareneoplastic limbic encephalitis
status epilepticus
title A Case of Autoimmune Encephalitis with Refractory Status Epilepticus
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T20%3A46%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Case%20of%20Autoimmune%20Encephalitis%20with%20Refractory%20Status%20Epilepticus&rft.jtitle=Archives%20of%20Epilepsy&rft.au=Merve%20Melodi%20%C3%87AKAR&rft.date=2019-01-01&rft.volume=25&rft.issue=3&rft.spage=165&rft.epage=168&rft.pages=165-168&rft.eissn=2792-0550&rft_id=info:doi/10.14744/epilepsi.2019.91259&rft_dat=%3Cdoaj%3Eoai_doaj_org_article_d2a77112403d4ead9701a3b7fa80129b%3C/doaj%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c242t-6715b7248a07a02636336b54a95fcc49f31d390246758876f4549d00abc7057e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true